Showing results (1-10 of 453) with videos related to

Sort By:
Pageof 46
Drugs|July 22, 2005
Drugs in development for hepatitis BMaria Buti, Rafael Esteban
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Preparing the patient for success: treat or wait?Maria Buti, Rafael Esteban
Expert Review of Gastroenterology & Hepatology|September 16, 2014
Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'Maria Buti, Rafael Esteban
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Triple therapy with boceprevir or telaprevir for treatment naïve HCV patientsRafael Esteban, Maria Buti
Clinics in Liver Disease|August 27, 2011
1990-2010: two decades of interferon-based therapyMaria Buti, Rafael Esteban
Journal of Hepatology|January 8, 2004
Entecavir, FTC, L-FMAU, LdT and othersMaria Buti, Rafael Esteban
Clinics in Liver Disease|October 1, 2021
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral TherapyMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Nucleos(t)ide analogue therapy: The role of tenofovir alafenamideMaria Buti, Cristina Marcos-Fosch, Rafael Esteban
Journal of Hepatology|August 25, 2015
Management of direct-acting antiviral agent failuresMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis BMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Pageof 46